This site is intended for health professionals only
Hospital Healthcare Europe
Register
Login
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
In depth
Views
Conference reports
Reviews & Research
Practice
Health technology
Sustainability
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Haematology
Immunology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Events
Upcoming events
On-demand learning
Clinical Excellence Catch-up
Partners
Register
Login
News
In depth
Views
Conference reports
Reviews & Research
Practice
Health technology
Sustainability
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Haematology
Immunology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Events
Upcoming events
On-demand learning
Clinical Excellence Catch-up
Partners
Register
Login
Home
>
Editor’s pick
Editor’s pick
I love New York
Ceplene rebuffed by EU regulator
Watchdog approves Nexium for GERD
Sharp rise in C difficile deaths
Sucampo files MAA for lubiprostone
Karo Bio reacquires compound rights from Radius
Novosis installs new transdermal technology
Recentin moves to phase III trial
NICE recommends MabThera for NHL
Ipsen reveals increase in profits
EMEA accepts Tolvaptan marketing authorisation application
Glide Pharma signs biologicals deal with major pharma company
« Previous
1
…
213
214
215
216
217
…
302
Next »
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: